node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
AvBD1 | AvBD6 | ENSGALP00000035925 | ENSGALP00000026847 | Gallinacin-1; Has bactericidal activity. Potent activity against E.coli ML- 35, L.monocytogenes EGD and C.albicans. | Gallinacin-6; Has bactericidal activity. Potent activity against S.typhimurium and S.entiriditis. | 0.987 |
AvBD1 | CAMP | ENSGALP00000035925 | ENSGALP00000030658 | Gallinacin-1; Has bactericidal activity. Potent activity against E.coli ML- 35, L.monocytogenes EGD and C.albicans. | Cathelicidin-2; Binds bacterial lipopolysaccharide (LPS). Has potent antimicrobial activity against Gram-positive and Gram-negative bacteria (in vitro). Has hemolytic activity (in vitro). May play a role in the innate immune response. | 0.931 |
AvBD1 | CATH1 | ENSGALP00000035925 | ENSGALP00000042184 | Gallinacin-1; Has bactericidal activity. Potent activity against E.coli ML- 35, L.monocytogenes EGD and C.albicans. | Cathelicidin-1; Binds bacterial lipopolysaccharide (LPS). Has potent antimicrobial activity against Gram-positive and Gram-negative bacteria (in vitro). Has hemolytic activity (in vitro). May play a role in the innate immune response. | 0.900 |
AvBD1 | CATH3 | ENSGALP00000035925 | ENSGALP00000056590 | Gallinacin-1; Has bactericidal activity. Potent activity against E.coli ML- 35, L.monocytogenes EGD and C.albicans. | Cathelicidin-3; May bind bacterial lipopolysaccharide (LPS). May have antimicrobial activity and play a role in the innate immune response (By similarity). | 0.845 |
AvBD1 | DEFB4A | ENSGALP00000035925 | ENSGALP00000030904 | Gallinacin-1; Has bactericidal activity. Potent activity against E.coli ML- 35, L.monocytogenes EGD and C.albicans. | Gallinacin-2; Potent antibacterial activity against the Gram-negative bacterium E.coli ML-35, and against the Gram-positive bacterium L.monocytogenes EGD. Lacks antifungal activity against C.albicans. | 0.994 |
AvBD1 | LECT2 | ENSGALP00000035925 | ENSGALP00000010210 | Gallinacin-1; Has bactericidal activity. Potent activity against E.coli ML- 35, L.monocytogenes EGD and C.albicans. | Myeloid protein 1. | 0.764 |
AvBD6 | AvBD1 | ENSGALP00000026847 | ENSGALP00000035925 | Gallinacin-6; Has bactericidal activity. Potent activity against S.typhimurium and S.entiriditis. | Gallinacin-1; Has bactericidal activity. Potent activity against E.coli ML- 35, L.monocytogenes EGD and C.albicans. | 0.987 |
AvBD6 | CAMP | ENSGALP00000026847 | ENSGALP00000030658 | Gallinacin-6; Has bactericidal activity. Potent activity against S.typhimurium and S.entiriditis. | Cathelicidin-2; Binds bacterial lipopolysaccharide (LPS). Has potent antimicrobial activity against Gram-positive and Gram-negative bacteria (in vitro). Has hemolytic activity (in vitro). May play a role in the innate immune response. | 0.856 |
AvBD6 | CATH1 | ENSGALP00000026847 | ENSGALP00000042184 | Gallinacin-6; Has bactericidal activity. Potent activity against S.typhimurium and S.entiriditis. | Cathelicidin-1; Binds bacterial lipopolysaccharide (LPS). Has potent antimicrobial activity against Gram-positive and Gram-negative bacteria (in vitro). Has hemolytic activity (in vitro). May play a role in the innate immune response. | 0.846 |
AvBD6 | CATH3 | ENSGALP00000026847 | ENSGALP00000056590 | Gallinacin-6; Has bactericidal activity. Potent activity against S.typhimurium and S.entiriditis. | Cathelicidin-3; May bind bacterial lipopolysaccharide (LPS). May have antimicrobial activity and play a role in the innate immune response (By similarity). | 0.705 |
AvBD6 | DEFB4A | ENSGALP00000026847 | ENSGALP00000030904 | Gallinacin-6; Has bactericidal activity. Potent activity against S.typhimurium and S.entiriditis. | Gallinacin-2; Potent antibacterial activity against the Gram-negative bacterium E.coli ML-35, and against the Gram-positive bacterium L.monocytogenes EGD. Lacks antifungal activity against C.albicans. | 0.986 |
AvBD6 | LECT2 | ENSGALP00000026847 | ENSGALP00000010210 | Gallinacin-6; Has bactericidal activity. Potent activity against S.typhimurium and S.entiriditis. | Myeloid protein 1. | 0.495 |
BLA | CAMP | ENSGALP00000066361 | ENSGALP00000030658 | MHC_II_alpha domain-containing protein. | Cathelicidin-2; Binds bacterial lipopolysaccharide (LPS). Has potent antimicrobial activity against Gram-positive and Gram-negative bacteria (in vitro). Has hemolytic activity (in vitro). May play a role in the innate immune response. | 0.833 |
CAMP | AvBD1 | ENSGALP00000030658 | ENSGALP00000035925 | Cathelicidin-2; Binds bacterial lipopolysaccharide (LPS). Has potent antimicrobial activity against Gram-positive and Gram-negative bacteria (in vitro). Has hemolytic activity (in vitro). May play a role in the innate immune response. | Gallinacin-1; Has bactericidal activity. Potent activity against E.coli ML- 35, L.monocytogenes EGD and C.albicans. | 0.931 |
CAMP | AvBD6 | ENSGALP00000030658 | ENSGALP00000026847 | Cathelicidin-2; Binds bacterial lipopolysaccharide (LPS). Has potent antimicrobial activity against Gram-positive and Gram-negative bacteria (in vitro). Has hemolytic activity (in vitro). May play a role in the innate immune response. | Gallinacin-6; Has bactericidal activity. Potent activity against S.typhimurium and S.entiriditis. | 0.856 |
CAMP | BLA | ENSGALP00000030658 | ENSGALP00000066361 | Cathelicidin-2; Binds bacterial lipopolysaccharide (LPS). Has potent antimicrobial activity against Gram-positive and Gram-negative bacteria (in vitro). Has hemolytic activity (in vitro). May play a role in the innate immune response. | MHC_II_alpha domain-containing protein. | 0.833 |
CAMP | CATH1 | ENSGALP00000030658 | ENSGALP00000042184 | Cathelicidin-2; Binds bacterial lipopolysaccharide (LPS). Has potent antimicrobial activity against Gram-positive and Gram-negative bacteria (in vitro). Has hemolytic activity (in vitro). May play a role in the innate immune response. | Cathelicidin-1; Binds bacterial lipopolysaccharide (LPS). Has potent antimicrobial activity against Gram-positive and Gram-negative bacteria (in vitro). Has hemolytic activity (in vitro). May play a role in the innate immune response. | 0.988 |
CAMP | CATH3 | ENSGALP00000030658 | ENSGALP00000056590 | Cathelicidin-2; Binds bacterial lipopolysaccharide (LPS). Has potent antimicrobial activity against Gram-positive and Gram-negative bacteria (in vitro). Has hemolytic activity (in vitro). May play a role in the innate immune response. | Cathelicidin-3; May bind bacterial lipopolysaccharide (LPS). May have antimicrobial activity and play a role in the innate immune response (By similarity). | 0.982 |
CAMP | DEFB4A | ENSGALP00000030658 | ENSGALP00000030904 | Cathelicidin-2; Binds bacterial lipopolysaccharide (LPS). Has potent antimicrobial activity against Gram-positive and Gram-negative bacteria (in vitro). Has hemolytic activity (in vitro). May play a role in the innate immune response. | Gallinacin-2; Potent antibacterial activity against the Gram-negative bacterium E.coli ML-35, and against the Gram-positive bacterium L.monocytogenes EGD. Lacks antifungal activity against C.albicans. | 0.928 |
CAMP | JUN | ENSGALP00000030658 | ENSGALP00000037247 | Cathelicidin-2; Binds bacterial lipopolysaccharide (LPS). Has potent antimicrobial activity against Gram-positive and Gram-negative bacteria (in vitro). Has hemolytic activity (in vitro). May play a role in the innate immune response. | Transcription factor AP-1; Transcription factor that recognizes and binds to the enhancer heptamer motif 5'-TGA[CG]TCA-3'. May be involved in activated KRAS-mediated transcriptional activation of USP28. May bind to the USP28 promoter; Belongs to the bZIP family. Jun subfamily. | 0.902 |